Dare Bioscience, Inc. — Director's Dealing 2015

Sep 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-02-23

Reporting Person: WALT DAVID R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-23	Stock Option (Right to Buy)	$4.80	A	22000	Acquired	2025-09-22	Common Stock (22000)	Direct

Footnotes

F1: This option was granted on September 23, 2015. The shares underlying this option vest in three equal installments on September 23, 2016, September 23, 2017 and September 23, 2018, respectively, subject to Mr. Walt's continued service as a director of the Corporation.